• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健中真性红细胞增多症诊断的挑战:一位有非典型表现的 55 岁马来西亚女性。

Challenges in Diagnosing Polycythemia Vera in Primary Care: A 55-Year-Old Malaysian Woman with Atypical Presentation.

机构信息

Department of Primary Care Medicine, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Sungai Buloh, Selangor, Malaysia.

Department of Medicine, Faculty of Medicine, Universiti Teknologi MARA (UiTM), Sungai Buloh, Selangor, Malaysia.

出版信息

Am J Case Rep. 2024 Sep 12;25:e944202. doi: 10.12659/AJCR.944202.

DOI:10.12659/AJCR.944202
PMID:39262095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404705/
Abstract

BACKGROUND Polycythemia vera (PV) is a myeloproliferative neoplasm (MPNs) marked by elevated hemoglobin and hematocrit, which can lead to thromboembolic events and progress to myelofibrosis or acute myeloid leukemia (AML). MPNs, including PV, are relatively rare in Malaysia, and there is currently no recent published data reporting the demographics and outcomes of PV patients in the country. In Western countries, routine annual blood tests are standard, whereas this practice is less common in Malaysia, underscoring the need for improved awareness and accessibility to ensure timely diagnosis of PV. CASE REPORT This report presents a case of a 55-year-old Malaysian woman in a primary care setting, initially misdiagnosed with benign conditions due to atypical presentations of recurrent bilateral eye redness and dizziness. Persistent symptoms led to further evaluation by primary care and hematologist, which revealed elevated hemoglobin, hematocrit, leukocytosis, JAK2 V617F mutation, and low serum erythropoietin levels, confirming PV, even without proceeding with a bone marrow biopsy. Treatment with phlebotomy, hydroxyurea, and aspirin resulted in significant improvements in ocular symptoms and hematological parameters within 60 days. CONCLUSIONS This case underscores the critical role of primary care in the early detection of polycythemia vera. Timely identification and appropriate referral from primary care settings are essential to avoid diagnostic delays and ensure effective management, improving patient outcomes and preventing complications.

摘要

背景

真性红细胞增多症(PV)是一种骨髓增殖性肿瘤(MPN),其特征为血红蛋白和血细胞比容升高,可导致血栓栓塞事件,并进展为骨髓纤维化或急性髓系白血病(AML)。MPN,包括 PV,在马来西亚相对罕见,目前尚无最近发表的数据报告该国 PV 患者的人口统计学和结局。在西方国家,常规进行年度血液检查是标准做法,而在马来西亚这种做法则不太常见,这突显了需要提高认识和可及性,以确保及时诊断 PV。

病例报告

本报告介绍了一名 55 岁马来西亚女性在初级保健环境中的病例,由于反复双侧眼红和头晕的非典型表现,最初被误诊为良性疾病。持续性症状导致初级保健医生和血液科医生进一步评估,发现血红蛋白、血细胞比容、白细胞增多、JAK2 V617F 突变和低血清促红细胞生成素水平升高,证实为 PV,甚至无需进行骨髓活检。通过放血、羟基脲和阿司匹林治疗,60 天内眼部症状和血液学参数显著改善。

结论

本病例强调了初级保健在早期发现真性红细胞增多症中的关键作用。及时从初级保健环境中识别和适当转诊对于避免诊断延迟和确保有效管理至关重要,这可以改善患者结局并预防并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c89/11404705/c003d79ff21d/amjcaserep-25-e944202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c89/11404705/151d3d798747/amjcaserep-25-e944202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c89/11404705/c003d79ff21d/amjcaserep-25-e944202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c89/11404705/151d3d798747/amjcaserep-25-e944202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c89/11404705/c003d79ff21d/amjcaserep-25-e944202-g002.jpg

相似文献

1
Challenges in Diagnosing Polycythemia Vera in Primary Care: A 55-Year-Old Malaysian Woman with Atypical Presentation.初级保健中真性红细胞增多症诊断的挑战:一位有非典型表现的 55 岁马来西亚女性。
Am J Case Rep. 2024 Sep 12;25:e944202. doi: 10.12659/AJCR.944202.
2
Polycythemia Vera.真性红细胞增多症。
Curr Treat Options Oncol. 2018 Mar 7;19(2):12. doi: 10.1007/s11864-018-0529-x.
3
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.真性红细胞增多症和原发性血小板增多症:2017 年诊断、危险分层和治疗更新。
Am J Hematol. 2017 Jan;92(1):94-108. doi: 10.1002/ajh.24607.
4
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.真性红细胞增多症和原发性血小板增多症:2015 年诊断、风险分层和治疗更新。
Am J Hematol. 2015 Feb;90(2):162-73. doi: 10.1002/ajh.23895.
5
Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.PRV-1 mRNA表达水平和JAK2V617F突变在真性红细胞增多症与继发性红细胞增多症鉴别诊断及干扰素或羟基脲治疗评估中的应用
Hematology. 2007 Dec;12(6):473-9. doi: 10.1080/10245330701384005.
6
The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.JAK2 V617F突变、自发性红细胞生成和巨核细胞生成、高敏血小板、活化白细胞以及内皮细胞在真性红细胞增多症和原发性血小板增多症血栓形成表现病因中的作用。
Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):381-98. doi: 10.1055/s-2006-942759.
7
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.真性红细胞增多症和原发性血小板增多症:2019 年诊断、风险分层和治疗更新。
Am J Hematol. 2019 Jan;94(1):133-143. doi: 10.1002/ajh.25303. Epub 2018 Nov 9.
8
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
9
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.真实生活中的细胞减灭治疗:1440 例真性红细胞增多症患者的图表回顾性分析。
J Cancer Res Clin Oncol. 2022 Oct;148(10):2693-2705. doi: 10.1007/s00432-021-03855-5. Epub 2021 Nov 22.
10
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.真性红细胞增多症和特发性血小板增多症:2012 年诊断、风险分层和治疗更新。
Am J Hematol. 2012 Mar;87(3):285-93. doi: 10.1002/ajh.23135.

引用本文的文献

1
Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases.聚焦JAK-STAT信号通路中的氨基酸改变突变:从疾病特异性突变到通用突变数据库
Sci Rep. 2025 Feb 20;15(1):6202. doi: 10.1038/s41598-025-90788-5.

本文引用的文献

1
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients.血栓形成对真性红细胞增多症患者死亡和疾病进展概率的影响:1545 例患者的多状态转移分析。
Blood Cancer J. 2023 Dec 15;13(1):187. doi: 10.1038/s41408-023-00960-1.
2
Moving toward disease modification in polycythemia vera.向真性红细胞增多症的疾病修饰治疗迈进。
Blood. 2023 Nov 30;142(22):1859-1870. doi: 10.1182/blood.2023021503.
3
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
真性红细胞增多症:2024 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26.
4
Diagnosis and Management of Cerebral Venous Thrombosis Due to Polycythemia Vera and Genetic Thrombophilia: Case Report and Literature Review.真性红细胞增多症和遗传性易栓症所致脑静脉血栓形成的诊断与管理:病例报告及文献综述
Life (Basel). 2023 Apr 24;13(5):1074. doi: 10.3390/life13051074.
5
Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.费城阴性经典型骨髓增殖性肿瘤中的原发性动脉高血压和药物性高血压:一项系统评价
Biomedicines. 2023 Jan 28;11(2):388. doi: 10.3390/biomedicines11020388.
6
Neuroimaging findings of hypercoagulable states: A case report on polycythemia vera (PV).高凝状态的神经影像学表现:真性红细胞增多症(PV)病例报告。
Neuroradiol J. 2023 Aug;36(4):496-499. doi: 10.1177/19714009221146002. Epub 2022 Dec 9.
7
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study.一种针对血红蛋白升高患者 JAK2 基因突变检测的合理方法:来自 JAK2 预测队列(JAKPOT)研究的结果。
J Gen Intern Med. 2023 Jun;38(8):1828-1833. doi: 10.1007/s11606-022-07963-x. Epub 2022 Nov 30.
8
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.国际髓系肿瘤和急性白血病共识分类:骨髓增殖性肿瘤。
Am J Hematol. 2023 Jan;98(1):166-179. doi: 10.1002/ajh.26751. Epub 2022 Oct 14.
9
Delayed diagnosis of polycythaemia vera in an adult female with non-cirrhotic portal hypertension.成年女性非肝硬化性门静脉高压症伴红细胞增多症的延迟诊断。
Ghana Med J. 2022 Mar;56(1):38-41. doi: 10.4314/gmj.v56i1.6.
10
Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe.真性红细胞增多症中的脾梗死并非总是一场灾难。
Eur J Case Rep Intern Med. 2022 Jun 29;9(6):003370. doi: 10.12890/2022_003370. eCollection 2022.